Cigarette smoking during pregnancy regulates the expression of specific nicotinic acetylcholine receptor (nAChR) subunits in the human placenta

Toxicology and Applied Pharmacology

Volumn 276, Issue 3, 2014, Pages 204-212

  Machaalani, R ^a,b   Ghazavi, E ^a   Hinton, T ^a   Waters, K A ^a,b   Hennessy, A ^c,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

^d HEART RESEARCH INSTITUTE   (Australia)

Author keywords

Infant; MRNA; Nicotine; Protein; Tissue and serum cotinine; Tobacco smoke

Indexed keywords

CIGARETTE SMOKE; COTININE; MESSENGER RNA; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR 1DELTA; NICOTINIC RECEPTOR 4BETA; NICOTINIC RECEPTOR 9ALPHA; NICOTINIC RECEPTOR EPSILON; NICOTINIC RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ADULT; AMPLICON; ARTICLE; BIRTH WEIGHT; BLOOD LEVEL; CESAREAN SECTION; CONTROLLED STUDY; DNA BASE COMPOSITION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; MATERNAL SMOKING; MELTING POINT; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; OPTICAL DENSITY; PLACENTA; PREGNANT WOMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; VAGINAL DELIVERY; WESTERN BLOTTING;

MAMMALIA; NICOTIANA TABACUM;

INFANT; MRNA; NICOTINE; PROTEIN; TISSUE AND SERUM COTININE; TOBACCO SMOKE;

COTININE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; PLACENTA; PREGNANCY; PROTEIN SUBUNITS; RECEPTORS, NICOTINIC; RNA, MESSENGER; SMOKING;

EID: 84897538634     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2014.02.015     Document Type: Article

References (85)

1. Benowitz N.L., Bernert J.T., Caraballo R.S., Holiday D.B., Wang J. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am. J. Epidemiol. 2009, 169:236-248.
2. Blount P., Merlie J.P. Molecular basis of the two nonequivalent ligand binding sites of the muscle nicotinic acetylcholine receptor. Neuron 1989, 3:349-357.
3. Brown H.L., Miller J.M., Khawli O., Gabert H.A. Premature placental calcification in maternal cigarette smokers. Obstet Gynecol 1988, 71:914-917.
4. Bukovsky A., Caudle M.R., Cekanova M., Fernando R.I., Wimalasena J., Foster J.S., Henley D.C., Elder R.F. Placental expression of estrogen receptor beta and its hormone binding variant-comparison with estrogen receptor alpha and a role for estrogen receptors in asymmetric division and differentiation of estrogen-dependent cells. Reprod. Biol. Endocrinol. 2003, 1:36.
5. Camacho P., Liu Y., Mandel G., Brehm P. The epsilon subunit confers fast channel gating on multiple classes of acetylcholine receptors. J. Neurosci. 1993, 13:605-613.
6. Carlisle D.L., Hopkins T.M., Gaither-Davis A., Silhanek M.J., Luketich J.D., Christie N.A., Siegfried J.M. Nicotine signals through muscle-type and neuronal nicotinic acetylcholine receptors in both human bronchial epithelial cells and airway fibroblasts. Respir. Res. 2004, 5:27.
7. Changeux J.P., Devillers-Thiery A., Galzi J.L., Revah F. The acetylcholine receptor: a model of an allosteric membrane protein mediating intercellular communication. CIBA Found. Symp. 1992, 164:66-89. (discussion 87-97).
8. Colomer C., Olivos-Ore L.A., Vincent A., McIntosh J.M., Artalejo A.R., Guerineau N.C. Functional characterization of alpha9-containing cholinergic nicotinic receptors in the rat adrenal medulla: implication in stress-induced functional plasticity. J. Neurosci. 2010, 30:6732-6742.
9. Cooper E., Couturier S., Ballivet M. Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature 1991, 350:235-238.
10. Corriveau R.A., Berg D.K. Coexpression of multiple acetylcholine receptor genes in neurons: quantification of transcripts during development. J. Neurosci. 1993, 13:2662-2671.
11. Di Angelantonio S., Matteoni C., Fabbretti E., Nistri A. Molecular biology and electrophysiology of neuronal nicotinic receptors of rat chromaffin cells. Eur. J. Neurosci. 2003, 17:2313-2322.
12. Dietz P.M., Homa D., England L.J., Burley K., Tong V.T., Dube S.R., Bernert J.T. Estimates of nondisclosure of cigarette smoking among pregnant and nonpregnant women of reproductive age in the United States. Am. J. Epidemiol. 2011, 173:355-359.
13. En-Nosse M., Hartmann S., Trinkaus K., Alt V., Stigler B., Heiss C., Kilian O., Schnettler R., Lips K.S. Expression of non-neuronal cholinergic system in osteoblast-like cells and its involvement in osteogenesis. Cell Tissue Res. 2009, 338:203-215.
14. Erel C.T., Dane B., Calay Z., Kaleli S., Aydinli K. Apoptosis in the placenta of pregnancies complicated with IUGR. Int. J. Gynaecol. Obstet. 2001, 73:229-235.
15. Eskenazi B., Prehn A.W., Christianson R.E. Passive and active maternal smoking as measured by serum cotinine: the effect on birthweight. Am. J. Public Health 1995, 85:395-398.
16. Fechter L.D., Thorne P.R., Nuttall A.L. Effects of carbon monoxide on cochlear electrophysiology and blood flow. Hear. Res. 1987, 27:37-45.
17. Francis M.M., Papke R.L. Muscle-type nicotinic acetylcholine receptor delta subunit determines sensitivity to noncompetitive inhibitors, while gamma subunit regulates divalent permeability. Neuropharmacology 1996, 35:1547-1556.
18. Genbacev O., Bass K.E., Joslin R.J., Fisher S.J. Maternal smoking inhibits early human cytotrophoblast differentiation. Reprod. Toxicol. 1995, 9:245-255.
19. Genbacev O., McMaster M.T., Zdravkovic T., Fisher S.J. Disruption of oxygen-regulated responses underlies pathological changes in the placentas of women who smoke or who are passively exposed to smoke during pregnancy. Reprod. Toxicol. 2003, 17:509-518.
20. Gerzanich V., Anand R., Lindstrom J. Homomers of alpha 8 and alpha 7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties. Mol. Pharmacol. 1994, 45:212-220.
21. Gotti C., Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog. Neurobiol. 2004, 74:363-396.
22. Govind A.P., Walsh H., Green W.N. Nicotine-induced upregulation of native neuronal nicotinic receptors is caused by multiple mechanisms. J. Neurosci. 2012, 32:2227-2238.
23. Grando S.A. Cholinergic control of epidermal cohesion. Exp. Dermatol. 2006, 15:265-282.
24. Green C.R., Rodgman A. The Tobacco Chemists' Research Conference a half century forum for advances in analytical methodology of tobacco and its products. Recent Adv. Tob. Sci. 1996, 22:131-304.
25. Guyon T., Wakkach A., Poea S., Mouly V., Klingel-Schmitt I., Levasseur P., Beeson D., Asher O., Tzartos S., Berrih-Aknin S. Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss. J. Clin. Invest. 1998, 102:249-263.
26. Hack M., Klein N.K., Taylor H.G. Long-term developmental outcomes of low birth weight infants. Future Child. 1995, 5:176-196.
27. Hardy J.B., Mellits E.D. Does maternal smoking during pregnancy have a long-term effect on the child?. Lancet 1972, 2:1332-1336.
28. Hoffman H.J., Damus K., Hillman L., Krongrad E. Risk factors for SIDS. Results of the National Institute of Child Health and Human Development SIDS Cooperative Epidemiological Study. Ann. N. Y. Acad. Sci. 1988, 533:13-30.
29. Horta B.L., Victora C.G., Menezes A.M., Halpern R., Barros F.C. Low birthweight, preterm births and intrauterine growth retardation in relation to maternal smoking. Paediatr. Perinat. Epidemiol. 1997, 11:140-151.
30. Jarvis M.J., Tunstall-Pedoe H., Feyerabend C., Vesey C., Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am. J. Public Health 1987, 77:1435-1438.
31. Jauniaux E., Burton G.J. The effect of smoking in pregnancy on early placental morphology. Obstet. Gynecol. 1992, 79:645-648.
32. Jauniaux E., Burton G.J. Morphological and biological effects of maternal exposure to tobacco smoke on the feto-placental unit. Early Hum. Dev. 2007, 83:699-706.
33. Kabbani N., Levenson R. A proteomic approach to receptor signaling: molecular mechanisms and therapeutic implications derived from discovery of the dopamine D2 receptor signalplex. Eur. J. Pharmacol. 2007, 572:83-93.
34. Ke L., Eisenhour C.M., Bencherif M., Lukas R.J. Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes. I. Dose- and time-dependent effects of nicotine treatment. J. Pharmacol. Exp. Ther. 1998, 286:825-840.
35. Kho E.M., North R.A., Chan E., Stone P.R., Dekker G.A., McCowan L.M. Changes in Doppler flow velocity waveforms and fetal size at 20weeks gestation among cigarette smokers. BJOG 2009, 116:1300-1306.
36. Klapproth H., Racke K., Wessler I. Acetylcholine and nicotine stimulate the release of granulocyte-macrophage colony stimulating factor from cultured human bronchial epithelial cells. Naunyn Schmiedebergs Arch. Pharmacol. 1998, 357:472-475.
37. Klesges L.M., Murray D.M., Brown J.E., Cliver S.P., Goldenberg R.L. Relations of cigarette smoking and dietary antioxidants with placental calcification. Am. J. Epidemiol. 1998, 147:127-135.
38. Kummer W., Lips K.S., Pfeil U. The epithelial cholinergic system of the airways. Histochem. Cell Biol. 2008, 130:219-234.
39. Kwon J.Y., Kim Y.H., Kim S.H., Kang M.H., Maeng Y.S., Lee K.Y., Park Y.W. Difference in the expression of alpha 7 nicotinic receptors in the placenta in normal versus severe preeclampsia pregnancies. Eur. J. Obstet. Gynecol. Reprod. Biol. 2006, 132:35-39.
40. Lam D.C., Girard L., Ramirez R., Chau W.S., Suen W.S., Sheridan S., Tin V.P., Chung L.P., Wong M.P., Shay J.W., Gazdar A.F., Lam W.K., Minna J.D. Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers. Cancer Res. 2007, 67:4638-4647.
41. Lambers D.S., Clark K.E. The maternal and fetal physiologic effects of nicotine. Semin. Perinatol. 1996, 20:115-126.
42. Le Novere N., Changeux J.P. Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells. J. Mol. Evol. 1995, 40:155-172.
43. Lee C.H., Chang Y.C., Chen C.S., Tu S.H., Wang Y.J., Chen L.C., Chang Y.J., Wei P.L., Chang H.W., Chang C.H., Huang C.S., Wu C.H., Ho Y.S. Crosstalk between nicotine and estrogen-induced estrogen receptor activation induces alpha9-nicotinic acetylcholine receptor expression in human breast cancer cells. Breast Cancer Res. Treat. 2011, 129:331-345.
44. Lips K.S., Bruggmann D., Pfeil U., Vollerthun R., Grando S.A., Kummer W. Nicotinic acetylcholine receptors in rat and human placenta. Placenta 2005, 26:735-746.
45. Liu J., Sakurai R., O'Roark E.M., Kenyon N.J., Torday J.S., Rehan V.K. PPARγ agonist rosiglitazone prevents perinatal nicotine exposure-induced asthma in rat offspring. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 300(5):L710-L717.
46. Macklin K.D., Maus A.D., Pereira E.F., Albuquerque E.X., Conti-Fine B.M. Human vascular endothelial cells express functional nicotinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 1998, 287:435-439.
47. Maison S.F., Luebke A.E., Liberman M.C., Zuo J. Efferent protection from acoustic injury is mediated via alpha9 nicotinic acetylcholine receptors on outer hair cells. J. Neurosci. 2002, 22:10838-10846.
48. Marubio L.M., Del Mar Arroyo-Jimenez M., Cordero-Erausquin M., Lena C., Le Novere N., De Kerchove D'Exaerde A., Huchet M., Damaj M.I., Changeux J.P. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 1999, 398:805-810.
49. Maus A.D., Pereira E.F., Karachunski P.I., Horton R.M., Navaneetham D., Macklin K., Cortes W.S., Albuquerque E.X., Conti-Fine B.M. Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Mol. Pharmacol. 1998, 54:779-788.
50. McIntosh J.M., Absalom N., Chebib M., Elgoyhen A.B., Vincler M. Alpha9 nicotinic acetylcholine receptors and the treatment of pain. Biochem. Pharmacol. 2009, 78:693-702.
51. Mielke J.G., Mealing G.A. Cellular distribution of the nicotinic acetylcholine receptor alpha7 subunit in rat hippocampus. Neurosci. Res. 2009, 65:296-306.
52. Mishina M., Takai T., Imoto K., Noda M., Takahashi T., Numa S., Methfessel C., Sakmann B. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature 1986, 321:406-411.
53. Murthi P., Fitzpatrick E., Borg A.J., Donath S., Brennecke S.P., Kalionis B. GAPDH, 18S rRNA and YWHAZ are suitable endogenous reference genes for relative gene expression studies in placental tissues from human idiopathic fetal growth restriction. Placenta 2008, 29:798-801.
54. Naeye R.L. Functionally important disorders of the placenta, umbilical cord, and fetal membranes. Hum. Pathol. 1987, 18:680-691.
55. Nelson D.M. Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast. Placenta 1996, 17:387-391.
56. Nelson M.E., Lindstrom J. Single channel properties of human alpha3 AChRs: impact of beta2, beta4 and alpha5 subunits. J. Physiol. 1999, 516(Pt 3):657-678.
57. Nelson D.M., Crouch E.C., Curran E.M., Farmer D.R. Trophoblast interaction with fibrin matrix. Epithelialization of perivillous fibrin deposits as a mechanism for villous repair in the human placenta. Am. J. Pathol. 1990, 136:855-865.
58. Nguyen V.T., Ndoye A., Grando S.A. Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity. Am. J. Pathol. 2000, 157:1377-1391.
59. Odendaal H.J., van Schie D.L., de Jeu R.M. Adverse effects of maternal cigarette smoking on preterm labor and abruptio placentae. Int. J. Gynaecol. Obstet. 2001, 74:287-288.
60. Oh S.Y., Chu T., Sadovsky Y. The timing and duration of hypoxia determine gene expression patterns in cultured human trophoblasts. Placenta 2011, 32:1004-1009.
61. Pastrakuljic A., Derewlany L.O., Koren G. Maternal cocaine use and cigarette smoking in pregnancy in relation to amino acid transport and fetal growth. Placenta 1999, 20:499-512.
62. Paulo J., Brucker W., Hawrot E. Proteomic analysis of an alpha7 nicotinic acetylcholine receptor interactome. J. Proteome Res. 2009, 8:1849-1858.
63. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
64. Pollock V.V., Pastoor T.E., Wecker L. Cyclic AMP-dependent protein kinase (PKA) phosphorylates Ser362 and 467 and protein kinase C phosphorylates Ser550 within the M3/M4 cytoplasmic domain of human nicotinic receptor alpha4 subunits. J. Neurochem. 2007, 103:456-466.
65. Quitadamo C., Fabbretti E., Lamanauskas N., Nistri A. Activation and desensitization of neuronal nicotinic receptors modulate glutamatergic transmission on neonatal rat hypoglossal motoneurons. Eur. J. Neurosci. 2005, 22:2723-2734.
66. Rollema H., Coe J.W., Chambers L.K., Hurst R.S., Stahl S.M., Williams K.E. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation. Trends Pharmacol. Sci. 2007, 28:316-325.
67. Rothlin C.V., Lioudyno M.I., Silbering A.F., Plazas P.V., Casati M.E., Katz E., Guth P.S., Elgoyhen A.B. Direct interaction of serotonin type 3 receptor ligands with recombinant and native alpha 9 alpha 10-containing nicotinic cholinergic receptors. Mol. Pharmacol. 2003, 63:1067-1074.
68. Sastry B.V. Placental toxicology: tobacco smoke, abused drugs, multiple chemical interactions, and placental function. Reprod. Fertil. Dev. 1991, 3:355-372.
69. Schluter P.J., Ford R.P., Ford C.J. A biochemical prevalence study of smoking in pregnancy for a cross-section of women in Christchurch, New Zealand. Aust. N. Z. J. Public Health 2002, 26:231-235.
70. Sgard F., Charpantier E., Bertrand S., Walker N., Caput D., Graham D., Bertrand D., Besnard F. A novel human nicotinic receptor subunit, alpha10, that confers functionality to the alpha9-subunit. Mol. Pharmacol. 2002, 61:150-159.
71. Soeda J., Morgan M., McKee C., Mouralidarane A., Lin C., Roskams T., Oben J.A. Nicotine induces fibrogenic changes in human liver via nicotinic acetylcholine receptors expressed on hepatic stellate cells. Biochem. Biophys. Res. Commun. 2012, 417:17-22.
72. Tang S., Machaalani R., Kashem M.A., Matsumoto I., Waters K.A. Intermittent hypercapnic hypoxia induced protein changes in the piglet hippocampus identified by MALDI-TOF-MS. Neurochem. Res. 2009, 34:2215-2225.
73. Wang N., Orr-Urtreger A., Chapman J., Rabinowitz R., Korczyn A.D. Deficiency of nicotinic acetylcholine receptor beta 4 subunit causes autonomic cardiac and intestinal dysfunction. Mol. Pharmacol. 2003, 63:574-580.
74. Verbitsky M., Rothlin C.V., Katz E., Elgoyhen A.B. Mixed nicotinic-muscarinic properties of the alpha9 nicotinic cholinergic receptor. Neuropharmacology 2000, 39:2515-2524.
75. Vetter D.E., Liberman M.C., Mann J., Barhanin J., Boulter J., Brown M.C., Saffiote-Kolman J., Heinemann S.F., Elgoyhen A.B. Role of alpha9 nicotinic ACh receptor subunits in the development and function of cochlear efferent innervation. Neuron 1999, 23:93-103.
76. Vincler M., Wittenauer S., Parker R., Ellison M., Olivera B.M., McIntosh J.M. Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:17880-17884.
77. Vogel C., Marcotte E.M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 2012, 13:227-232.
78. Vyhlidal C.A., Riffel A.K., Haley K.J., Sharma S., Dai H., Tantisira K.G., Weiss S.T., Leeder J.S. Cotinine in human placenta predicts induction of gene expression in fetal tissues. Drug Metab. Dispos. 2013, 41:305-311.
79. Wang F., Gerzanich V., Wells G.B., Anand R., Peng X., Keyser K., Lindstrom J. Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits. J. Biol. Chem. 1996, 271:17656-17665.
80. Wang Q.Q., Zhao X., Pu X.P. Proteome analysis of the left ventricle in the vitamin D(3) and nicotine-induced rat vascular calcification model. J. Proteome 2011, 74:480-489.
81. Whiteaker P., Cooper J.F., Salminen O., Marks M.J., McClure-Begley T.D., Brown R.W., Collins A.C., Lindstrom J.M. Immunolabeling demonstrates the interdependence of mouse brain alpha4 and beta2 nicotinic acetylcholine receptor subunit expression. J. Comp. Neurol. 2006, 499:1016-1038.
82. Xu W., Gelber S., Orr-Urtreger A., Armstrong D., Lewis R.A., Ou C.N., Patrick J., Role L., De Biasi M., Beaudet A.L. Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:5746-5751.
83. Xu W., Orr-Urtreger A., Nigro F., Gelber S., Sutcliffe C.B., Armstrong D., Patrick J.W., Role L.W., Beaudet A.L., De Biasi M. Multiorgan autonomic dysfunction in mice lacking the beta2 and the beta4 subunits of neuronal nicotinic acetylcholine receptors. J. Neurosci. 1999, 19:9298-9305.
84. Zevin S., Gourlay S.G., Benowitz N.L. Clinical pharmacology of nicotine. Clin. Dermatol. 1998, 16:557-564.
85. Zia S., Ndoye A., Lee T.X., Webber R.J., Grando S.A. Receptor-mediated inhibition of keratinocyte migration by nicotine involves modulations of calcium influx and intracellular concentration. J. Pharmacol. Exp. Ther. 2000, 293:973-981.